Package 72485-213-15

Brand: irinotecan hydrochloride

Generic: irinotecan hydrochloride
NDC Package

Package Facts

Identity

Package NDC 72485-213-15
Digits Only 7248521315
Product NDC 72485-213
Product ID 72485-213_16bc41f7-c83f-473e-bf17-9e6328cecb4b
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (72485-213-15) / 15 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2020-09-04
Brand irinotecan hydrochloride
Generic irinotecan hydrochloride
Sample Package No

Linked Drug Pages (1)

Irinotecan Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "16bc41f7-c83f-473e-bf17-9e6328cecb4b", "openfda": {"upc": ["0372485213153"], "unii": ["042LAQ1IIS"], "rxcui": ["1726333"], "spl_set_id": ["6a186e60-6ea1-4450-9668-dac7dd7a03e3"], "manufacturer_name": ["Armas Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (72485-213-15)  / 15 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "72485-213-15", "marketing_start_date": "20200904"}], "brand_name": "Irinotecan Hydrochloride", "product_id": "72485-213_16bc41f7-c83f-473e-bf17-9e6328cecb4b", "dosage_form": "INJECTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "72485-213", "generic_name": "Irinotecan Hydrochloride", "labeler_name": "Armas Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irinotecan Hydrochloride", "active_ingredients": [{"name": "IRINOTECAN HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA208718", "marketing_category": "ANDA", "marketing_start_date": "20200904", "listing_expiration_date": "20261231"}